Sean Sullivan

Sean Sullivan

Company: Arcturus Therapeutics

Job title: Vice President Technology Innovation and Development

Seminars:

Enhancing T Cell Immunogenicity With Self-Amplifying RNA: Lessons from Arcturus’ Next-Gen Platform Development 9:30 am

• How to leverage self-amplifying RNA (saRNA) to increase antigen expression and prolong immune stimulation – and why this matters for robust T cell priming in cancer vaccines • Comparative insights on saRNA vs. conventional mRNA for driving cellular immune responses, and where each platform may hold distinct clinical advantages • Considerations for integrating saRNA…Read more

day: Conference Day Two

Scaling What’s Never Been Scaled: Lessons Learned From Building Late- Stage Manufacturing Readiness for Global PCV Trials 9:00 am

• How to design a scalable, modular manufacturing model to enable Phase II/III execution without overcommitting pre-commercial – including lessons from scaledown modeling to simulate future bottlenecks • Strategic considerations in platform selection and core workflow standardization to support repeatability, reduce cost, and accelerate late-stage development • Lessons from early investments in future-proofing critical processes…Read more

day: Pre-Conference Manufacturing Focus Day

A Hanson Wade Group Company

© Copyright 2025 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.